QuidelOrtho Corp QDEL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
QuidelOrtho Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of QuidelOrtho Corporation - QDEL
QDEL SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving QuidelOrtho
QuidelOrtho Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into QuidelOrtho (QDEL)
QuidelOrtho Reports Third Quarter 2026 Financial Results
QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026
QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?
QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations
Trading Information
- Previous Close Price
- $11.52
- Day Range
- $11.40–12.21
- 52-Week Range
- $9.92–35.58
- Bid/Ask
- $11.91 / $12.27
- Shares Outstanding
- 68.61M
- Market Cap
- $817.18M
- Volume/Avg
- 2M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 8.54
- Price/Sales
- 0.30
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 6,500
- Website
- https://www.quidelortho.com
Valuation
Metric | QDEL |
|---|---|
Price/Earnings (Normalized) | 8.54 |
Price/Book Value | 0.44 |
Price/Sales | 0.30 |
Price/Cash Flow | 4.83 |
Price/Earnings
QDEL
Financial Strength
Metric | QDEL |
|---|---|
Quick Ratio | 0.62 |
Current Ratio | 1.36 |
Interest Coverage | −0.68 |
Quick Ratio
QDEL
Profitability
Metric | QDEL |
|---|---|
Return on Assets (Normalized) | 1.03% |
Return on Equity (Normalized) | 3.15% |
Return on Invested Capital (Normalized) | 4.29% |
Return on Assets
QDEL
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|gGg@ND | LOCK|bpWF | $191B | |||
| Medtronic PLC MDT | LOCK|mgSB#%s | LOCK|^M@?! | $130B | |||
| Stryker Corp SYK | LOCK|H$R?Pcm | LOCK|XXt | $123B | |||
| Boston Scientific Corp BSX | LOCK|qCh%TH | LOCK|FlRg | $65B | |||
| Edwards Lifesciences Corp EW | LOCK|r$$Y$LL | LOCK|@dY> | $60B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|$yz><hG | LOCK|Wp | $38B | |||
| DexCom Inc DXCM | LOCK|%#KrzR%@ | LOCK|#NRhf | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|?Jh | LOCK|>z | $30B | |||
| Steris PLC STE | LOCK|gWv&KhY | LOCK|?QDW | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|@$Z?l&M | LOCK|fB | $20B |
United States